Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to ARRYXIN
ARRYXIN Injection is a clinically formulated treatment specifically aimed at enhancing cardiac function in patients with heart failure. Its innovative composition targets key aspects of cardiac performance to support overall heart health.
Uses of ARRYXIN
Heart Failure Management: Indicated for patients with reduced left ventricular ejection fraction.
Symptom Relief: Aids in the reduction of heart failure symptoms, promoting a better quality of life.
Benefits of ARRYXIN
Increased Left Ventricular Ejection Fraction: Supports improved heart efficiency and performance.
Enhanced Exercise Capacity: Facilitates increased physical activity levels, leading to better patient outcomes.
Symptomatic Improvement: Significantly alleviates symptoms associated with heart failure.
Mechanism of Action of ARRYXIN
ARRYXIN works by optimizing myocardial contractility and enhancing cardiac output. Its pharmacological properties are designed to promote improved ventricular function, ultimately leading to a more robust heart performance in individuals with heart failure.